ArticleThe European respiratory journal2023
Article in The European respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Current Perspectives onInternational journal of molecular sciences · 2026Review
- Global lineages of non-tuberculous mycobacteria in residential water samples from Germany.BMC microbiology · 2025Article
- Genomic characterisation of recurrent Mycobacterium avium isolates from chronically infected patients reveals patterns of within-host evolution.Genome medicine · 2025Article
- TheMicroorganisms · 2025Review
- Whole-genome phylogenetic analysis ofMicrobiology spectrum · 2025Article
- Clinical and genomic features of Mycobacterium avium complex: a multi-national European study.Genome medicine · 2024Article
- Genomic epidemiology ofERJ open research · 2024Article
- Article
- Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria.Scientific reports · 2024Article
- Genomic diversity and clinical relevance ofERJ open research · 2024Article
Corrections and comments
- Commented on byTransmission of2023
Authors and funding
10 authors.
Funding
Abstract
backgroundNon-tuberculous mycobacteria (NTM) are environmental microorganisms and opportunistic pathogens in individuals with pre-existing lung conditions such as cystic fibrosis (CF) and non-CF bronchiectasis. While recent studies of
methodsTo investigate the potential for transmission of the
resultsWe identified putative transmission clusters in three MAC species, although few epidemiological links could be identified. For
conclusionsCF and non-CF patients shared transmission chains, although the lack of epidemiological links suggested that most transmission is indirect and may involve environmental intermediates or asymptomatic carriage in the wider population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.